7 April 2014
Vascutek’s AnacondaTM AAA Stent Graft System Approved for Expanded Indication
Vascutek is pleased to announce that it has received CE mark approval for AnacondaTm to be used to treat infra-renal abdominal aortic aneurysms in patients with proximal aortic neck angulation of ≤ 90 degrees providing a clinical solution for patients with tortuous anatomy.
The AnacondaTM stent graft is designed to deliver exceptional flexibility with innovative ring stent technology to provide a proactive sealing system which conforms to the natural anatomy of the patient. The ability to fully reposition enables clinicians to deliver the system accurately to the target even in challenging anatomy.
Vascutek’s Vice-President of Sales, Marketing and Clinical Services, Alan Rogers, said: “As EVAR techniques have evolved over the years, AnacondaTM has provided clinicians with a solution for a wide-range of patient anatomies.”
The 90 degree indication for AnacondaTM provides clinicians with a treatment to manage those patients presenting with challenging anatomies.
The AnacondaTM Stent Graft System is used to treat abdominal aortic aneurysms. More than 17,000 AnacondaTM stent grafts have been implanted since the system was launched in 2005.
Tel: 00 44 141 333 0557
Mobile: +44 7770 886934